We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

8 hedge funds and large institutions have $210K invested in Arcadia Biosciences in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.98% less ownership

Funds ownership: 9.78% → 1.8% (-8%)

27% less funds holding

Funds holding: 11 → 8 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

91% less capital inflows, than outflows

Capital inflows: $152K | Capital outflows: $1.7M

Holders
8
Holders Change
-3
Holders Change %
-27.27%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$112K
2
Virtu Financial
Virtu Financial
New York
+$23.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.15K
4
Goldman Sachs
Goldman Sachs
New York
+$5.64K
5
UBS Group
UBS Group
Switzerland
+$3.25K

Top Sellers

Rank Fund Capital Flow
1
Waddell & Reed Financial
Waddell & Reed Financial
Kansas
-$1.63M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$41K
3
Creative Planning
Creative Planning
Kansas
-$19K
4
Bridgeway Capital Management
Bridgeway Capital Management
Texas
-$17K

RKDA Hedge Fund Activity: Q4 2017 in Review

8 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2017, worth a combined $210K — down 88% from $1.79M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of RKDA and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $112K. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $1.63M sold.

  • 8 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2017, down from 11 in Q3 2017.
  • Funds reported $210K of Arcadia Biosciences stock for Q4 2017, down 88% quarter-over-quarter.
  • 2 funds opened new Arcadia Biosciences positions in Q4 2017 and 5 closed out, a net change of -3 holders.
  • The largest Arcadia Biosciences buyer in Q4 2017 was Renaissance Technologies, an estimated $112K added.
  • The largest Arcadia Biosciences seller in Q4 2017 was Waddell & Reed Financial, an estimated $1.63M sold.

Based on aggregated 13F filings for Q4 2017.